Document Detail


Access-site complications after rescue percutaneous coronary intervention during thrombolysis for acute myocardial infarction.
MedLine Citation:
PMID:  15668826     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Aggressive antithrombotic medical therapy may increase the rate of access-site complications after percutaneous coronary intervention. Frequently, emergency coronary interventions have to be performed in a situation when thrombolysis therapy was administered as the first-line therapeutic approach in acute myocardial infarction but failed to achieve stable conditions. We analyzed the rate of femoral bleeding complications after emergency coronary intervention in 76 consecutive patients with unsuccessful thrombolysis in acute myocardial infarction. All invasive procedures were performed in a time period no longer than eight hours after thrombolysis was administered. Additional antithrombotic therapy with heparin and glycoprotein IIb/IIIa-inhibitors was given during intervention in 100% and 38.2% of patients, respectively. In three patients (3.9%) femoral hematomas without therapeutic consequences were documented; one patient (1.3%) developed a hematoma requiring blood transfusion. A pseudoaneurysm, fistula or surgical vascular intervention did not occur. Coronary interventional procedures in rescue situations can be performed with excellent safety with respect to access-site bleeding complications even under conditions of ongoing thrombolysis therapy and aggressive antithrombotic medical regimens.
Authors:
A Germing; M Lindstaedt; S Ulrich; W Bojara; T Lawo; A Mügge; P Grewe
Related Documents :
6090146 - Assessment of myocardial necrosis immediately after intracoronary thrombolysis by intra...
16126256 - Alteplase treatment affects circulating matrix metalloproteinase concentrations in pati...
21530166 - Left atrial volume by real-time three-dimensional echocardiography: validation by 64-sl...
10522956 - Delayed thrombolytic treatment of older patients with acute myocardial infarction.
8869136 - Potential role of angiotensin converting enzyme inhibitors in treatment of atherosclero...
23801796 - Prognostic value of multidetector computed tomography coronary angiography in diabetes:...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Zeitschrift für Kardiologie     Volume:  94     ISSN:  0300-5860     ISO Abbreviation:  Z Kardiol     Publication Date:  2005 Jan 
Date Detail:
Created Date:  2005-01-25     Completed Date:  2005-05-31     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  0360430     Medline TA:  Z Kardiol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  23-7     Citation Subset:  IM    
Affiliation:
Medizinische Klinik II, Kardiologie und Angiologie, Berufsgenossenschaftliche Kliniken Bergmannsheil, Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany. alfried.germing@ruhr-uni-bochum.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Angioplasty, Transluminal, Percutaneous Coronary*
Coronary Angiography*
Drug Therapy, Combination
Emergencies*
Female
Femoral Artery*
Fibrinolytic Agents / adverse effects*,  therapeutic use
Hematoma / chemically induced
Heparin / adverse effects,  therapeutic use
Humans
Male
Middle Aged
Myocardial Infarction / radiography,  therapy*
Platelet Glycoprotein GPIIb-IIIa Complex / adverse effects,  therapeutic use
Postoperative Hemorrhage / chemically induced*
Retreatment
Risk Factors
Thrombolytic Therapy*
Treatment Failure
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; 0/Platelet Glycoprotein GPIIb-IIIa Complex; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacological cardioversion of atrial fibrillation
Next Document:  Combined cardiothoracic surgery and interventions of the para/thyroid gland. A rare clinical coopera...